JPMorgan downgrades Pliant Therapeutics stock rating to Underweight from Neutral By Invest - Stock Watch Index

JPMorgan downgrades Pliant Therapeutics stock rating to Underweight from Neutral By Invest

October 10, 2025

JPMorgan downgrades Pliant Therapeutics stock rating to Underweight from Neutral

Search

RECENT PRESS RELEASES

Investors are betting $21 billion that the energy transition isn’t going away

SWI Editorial Staff2025-10-10T09:11:39-07:00October 10, 2025|

Office for Sustainability releases annual report: Reflects progress, opportunities

SWI Editorial Staff2025-10-10T09:11:18-07:00October 10, 2025|

Trump officials cancel major solar project in latest hit to renewable energy

SWI Editorial Staff2025-10-10T09:10:48-07:00October 10, 2025|

Amazon Offers Sneakiest Of Peeks At Its Controversial New ‘Melania’ Documentary

SWI Editorial Staff2025-10-10T09:10:22-07:00October 10, 2025|

Neil Young rants about Donald Trump and Jeff Bezos as he pulls his music from Amazon

SWI Editorial Staff2025-10-10T09:09:50-07:00October 10, 2025|

October Prime Day may be over, but these 58 deals are still live for a limited time

SWI Editorial Staff2025-10-10T09:09:25-07:00October 10, 2025|

Related Post